April, 2010 | Khurana And Khurana Advocates and IP Attorneys

Actavis and Novartis

15th April, 2010 - 3:52 am Categories: Patent Litigation Pharma/Biotech Patent Litigations

ACTAVIS’ “EXPECTATION OF SUCCESS” AFFIRMED ACTAVIS UK vs NOVARTIS AG The High Court, Court of Appeal has recently upheld a decision on Appeal from the High Court, Patents Court, that the Novartis’s European Patent (UK) 0948320, a sustained release formulation of Fluvastatin (a Cholesterol lowering drug), is invalid on the ground of obviousness. Earlier in … Continue reading Actavis and Novartis

Nokia & Ipcom

11th April, 2010 - 4:47 am Categories: Patent Litigation

0 Comments

Introduction: It all started when the licensing deal between Nokia and Ipcom broke in Germany. From then, it was a legal war between these two giants. While Ipcom along with its bunch of patents trying to target each and every mobile model of its rivalry, Nokia trying to revocate Ipcom’s each patent one by one. … Continue reading Nokia & Ipcom

Eli Lilly Vs Sun Pharma and others

9th April, 2010 - 9:56 am Categories: Patent Litigation Pharma/Biotech Patent Litigations

0 Comments

Lilly’s Patent relates to method of treating Attention-Deficit/ Hyperactivity disorder (ADHD) with administration of effective amount of Tomoxetine. Lilly markets atomoxetine capsule under the brand name STRATTERA®. The US Patent 5,658,590 was assigned to Lilly On August 19, 1997 with a principal claim that recites a particular method of treating ADHD. Submission of an Abbreviated … Continue reading Eli Lilly Vs Sun Pharma and others

Month: April 2010

Actavis and Novartis

Nokia & Ipcom

Eli Lilly Vs Sun Pharma and others

Categories

Archives